Boston Scientific (BSX)

Cost of Revenue

$6.06B

TTM · Period ending: · USD

BSX logo

BSX Cost of Revenue

Latest reported$6.06B
BSX TTM Cost of Revenue ($0.00 → $6.06B)
High-resolution chart · PNG

BSX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,055,000,000
6,098,000,000
6,221,000,000
6,763,000,000
6,801,000,000
6,699,000,000
6,458,000,000
5,981,000,000
5,780,000,000
5,568,000,000
5,408,000,000
5,282,000,000
5,164,000,000
5,097,000,000
4,968,000,000
4,867,000,000
4,725,000,000
4,604,000,000
4,506,000,000
4,527,000,000
4,513,000,000
4,394,000,000
4,339,000,000
4,210,000,000
4,101,000,000
4,020,000,000
3,889,000,000
3,696,000,000
3,527,000,000
3,452,000,000
3,344,000,000
3,259,000,000
3,230,000,000
3,159,000,000
3,171,000,000
3,131,000,000
3,095,000,000
2,965,000,000
2,754,000,000
2,584,000,000
2,397,000,000
2,296,000,000
2,241,000,000
2,235,000,000
2,250,000,000
2,280,000,000
2,320,000,000
2,315,000,000
2,282,000,000
2,271,000,000
2,313,000,000
2,345,000,000
2,365,000,000
2,366,000,000
2,378,000,000
2,427,000,000
2,549,000,000
2,659,000,000
2,659,000,000
2,659,000,000
2,602,000,000
2,568,000,000
2,600,000,000
2,649,000,000
2,655,000,000
2,631,000,000
2,575,000,000
2,496,000,000
2,522,000,000
2,496,000,000
2,469,000,000
2,475,000,000
2,395,000,000
2,354,000,000
2,342,000,000
2,232,000,000
2,287,000,000
2,401,000,000
2,207,000,000
2,023,000,000
1,736,000,000
1,416,000,000
1,386,000,000
1,372,000,000
1,338,000,000
1,344,000,000
1,292,000,000
1,221,000,000
1,155,000,000
1,027,000,000
961,000,000
931,000,000
899,000,000
889,000,000
870,000,000
858,000,000
861,000,000
904,000,000
919,000,000
816,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.